MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · The Journal of invasive cardiology · 2012

Unrestricted use of endeavor resolute zotarolimus-eluting stent in daily clinical practice: a prospective registry.

Galasso Gennaro, Piccolo Raffaele, Cassese Salvatore, Esposito Giovanni, Cirillo Plinio, Leosco Dario, Rapacciuolo Antonio, Sirico Domenico, De Biase Chiara, Niglio Tullio, Piscione Federico

Сравнительное исследованиеОценочное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

To evaluate the safety and efficacy of unrestricted Endeavor Resolute zotarolimus-eluting stent (ZES) use. Furthermore, we sought to evaluate clinical outcomes associated with on- and off-label use of Resolute ZES.

METHODS

The current study was a prospective, single-center registry. The primary endpoint was major adverse cardiac events (MACE), defined as the composite of death, myocardial infarction (MI), and target-vessel revascularization (TVR). Secondary endpoints were death, MI, TVR, and stent thrombosis (ST).

RESULTS

A total of 370 patients were prospectively enrolled. Off-label Resolute ZES use was performed in 311 patients (84%). At a mean follow-up of 17.3 ± 6 months, MACE occurred in 31 patients (8.5%), death in 15 (4.1%), MI in 10 (2.7%), and TVR in 19 (5.2%). Definite, probable, and possible ST occurred in 9 patients (2.5%). Off-label Resolute ZES implantation, as compared to on-label use, was not associated with an increased risk of MACE (9.4% vs 3.4%; P=.13), death (4.9% vs 0%; P=.14), MI (3.3% vs 0%; P=.38), and TVR (5.5% vs 3.4%; P=.75). On multivariable analysis, previous revascularization (P=.008), but not off-label Resolute ZES implantation (P=.07), was associated with MACE.

CONCLUSIONS

In daily clinical practice, Resolute ZES was mostly implanted in patients with off-label indications and associated with a relatively low rate of MACE and TVR.

Для цитирования: Galasso Gennaro, Piccolo Raffaele, Cassese Salvatore, Esposito Giovanni, Cirillo Plinio, Leosco Dario, Rapacciuolo Antonio, Sirico Domenico, De Biase Chiara, Niglio Tullio, Piscione Federico. Unrestricted use of endeavor resolute zotarolimus-eluting stent in daily clinical practice: a prospective registry.. The Journal of invasive cardiology. 2012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.